Streptococcus agalactiae or group B streptococcus (GBS) is a leading cause of serious
neonatal infections. GBS is an opportunistic commensal constituting a part of the intestinal …

Streptococcus agalactiae, or group B streptococcus (GBS), is a major neonatal pathogen.
Recent data have elucidated the global prevalence of maternal and neonatal colonization …

Using serotyping, multilocus sequence typing, and whole-genome sequencing (WGS) of
selected strains, we studied the population structure of 102 group B Streptococcus (GBS) …

Abstract Background. Group B Streptococcus (GBS) is a major cause of neonatal sepsis and
meningitis. A vaccine targeting pregnant women could protect infants through placentally …

We studied the bacterial characteristics and incidence of invasive infections caused by
group B streptococci (GBS) in adults in Iceland in 1975–2014. A total of 145 isolates were …

Group B streptococci (GBS) cause severe invasive disease in both neonates and adults.
Understanding the epidemiology of GBS provides information that can include determining …

Background: The characteristics of group B streptococcus (GBS) neonatal disease in a
period of 7 years are reported. Methods: The estimation of the neonatal GBS disease risk …

Abstract Background Group B Streptococcus (GBS) is an important pathogen that causes
high mortality and morbidity in young infants. However, data on clinical manifestations …

Aims To evaluate the prevalence, molecular characteristics, antimicrobial susceptibility, and
epithelial invasion of Streptococcus agalactiae strains isolated from pregnant women and …

We investigated the antibiotic and heavy-metal resistance mechanisms, virulence genes
and clonal relationships of macrolide-and/or lincosamide-resistant (M+/− LR) Streptococcus …